375
Views
15
CrossRef citations to date
0
Altmetric
Letter to the Editor

Multirater Validation of Peripapillary Hyperreflective Ovoid Mass-like Structures (PHOMS)

ORCID Icon, , , , , , ORCID Icon, , , , , , , , , , , , , ORCID Icon, , , , , , & show all
Pages 413-414 | Received 07 Mar 2020, Accepted 22 Apr 2020, Published online: 16 Jul 2020
 

ABSTRACT

Peripapillary hyperreflective ovoid mass-like structures (PHOMS) are a new retinal optical coherence tomography (OCT) finding. The Optic Disc Drusen Studies Consortium had made recommendations to distinguish PHOMS from true optic disc drusen (ODD) in 2018. While publications on PHOMS have increased since then, the accuracy of the definition of PHOMS and reliability of detection is unknown. In this multi-rater study, we demonstrate that the 2018 definition of PHOMS resulted in a poor multi-rater kappa of 0.356. We performed a Delphi consensus process to develop a consistent and refined definition of PHOMS with clear principles around the nature of PHOMS and how they differ from normal anatomy. Fifty explanatory teaching slides, provided as supplementary material, allowed our expert group of raters to achieve a good level of agreement (kappa 0.701, 50 OCT scans, 21 raters). We recommend adopting the refined definition for PHOMS.

KEYWORDS:

Supplemental data for this article can be accessed online at http://dx.doi.org/10.1080/01658107.2020.1760891.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.